Results Press Release for June 30, 2016
Pfizer Ltd has informed BSE about : 1. Result Press Release for the period ended June 30, 201606-08-2016
06-08-2016
Updates
Pfizer Ltd has informed BSE that a teleconference call has been scheduled with the analysts on August 08, 2016, at 4.00 p.m. to discuss the Company's financial performance for the quarter ended June 30, 2016.06-08-2016
Pfizer Q1 net rises 6% to Rs80 crore
Pfizer standalone total income from operations rose to Rs501 crore as against Rs483 crore for the same period a year ago05-08-2016
Announces Q1 results (Standalone) & Limited Review Report (Standalone) for the Quarter ended June 30, 2016
Pfizer Ltd has announced the following Unaudited Standalone results for the quarter ended June 30, 2016:The Company has posted a net profit of Rs. 800.40 million for the quarter ended June 30, 2016 as compared to Rs. 751.70 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 5002.80 million for the quarter ended June 30, 2015 to Rs. 5227.70 million for the quarter ended June 30, 2016.05-08-2016
MSF and Pfizer battle over patent application for life-saving pneumonia vaccine
MSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious and predictable.29-07-2016
Q1 results on August 05, 2016
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on Friday, August 05, 2016, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter and three months ended June 30, 2016 (Q1).Further, the Trading Window for trading in the Equity shares of the Company will be closed from July 27, 2016 to August 07, 2016, both days inclusive.26-07-2016
Shareholding for the Period Ended June 30, 2016
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here20-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Pfizer Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.18-07-2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Pfizer Ltd has informed BSE regarding the details of Voting results at the 65th Annual General Meeting (AGM) of the Company held on July 05, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.07-07-2016
Outcome of AGM
Pfizer Ltd has informed BSE that the 65th Annual General Meeting (AGM) of the Company was held on July 05, 2016.06-07-2016